93 Renal Health
Akwo, E., Robinson-Cohen, C., Chung, C. P., Wilson, P. W. F., O’Donnell, C., Edwards, T. L., Kovesdy, C. P., & Hung, A. (2020). 4577 resistant hypertension potentiates the risk of end-stage kidney disease among African-Americans independent of APOL1 genotype in the Million Veteran Program. Journal of Clinical and Translational Science, 4(S1), 36–36. https://doi.org/10.1017/cts.2020.144
Appaneal, H. J., Caffrey, A. R., Lopes, V. V., Crnich, C. J., Dosa, D. M., & LaPlante, K. L. (2019). National trends in the treatment of urinary tract infections among Veterans’ Affairs community living center residents. Infection Control & Hospital Epidemiology, 40(10), 1087–1093. https://doi.org/10.1017/ice.2019.204
Choi, D. T., Puenpatom, A., Yu, X., Erickson, K. F., Kanwal, F., El-Serag, H. B., & Kramer, J. R. (2020). Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. Antiviral Research, 174, 104698. https://doi.org/10.1016/j.antiviral.2019.104698
DeRosa, A., Carter, M. T., Wattengel, B. A., Lesse, A. J., Sellick, J. A., & Mergenhagen, K. A. (2020). Antimicrobial susceptibility trends for urinary isolates in the veteran population. American Journal of Infection Control. https://doi.org/10.1016/j.ajic.2020.10.007
Ganesan, C., Weia, B., Thomas, I.-C., Song, S., Velaer, K., Seib, C. D., Conti, S., Elliott, C., Chertow, G. M., Tamura, M. K., Leppert, J. T., & Pao, A. C. (2020). Analysis of primary hyperparathyroidism screening among US veterans with kidney stones. JAMA Surgery, 155(9), 861–868. https://doi.org/10.1001/jamasurg.2020.2423
Goode, P. S., Markland, A. D., Echt, K. V., Slay, L., Barnacastle, S., Hale, G., Wright, M. K., Lane, T. R., & Burgio, K. L. (2020). A mobile telehealth program for behavioral treatment of urinary incontinence in women veterans: Development and pilot evaluation of MyHealtheBladder. Neurourology and Urodynamics, 39(1), 432–439. https://doi.org/10.1002/nau.24226
Hellwege, J. N., Velez Edwards, D. R., Giri, A., Qiu, C., Park, J., Torstenson, E. S., Keaton, J. M., Wilson, O. D., Robinson-Cohen, C., Chung, C. P., Roumie, C. L., Klarin, D., Damrauer, S. M., DuVall, S. L., Siew, E., Akwo, E. A., Wuttke, M., Gorski, M., Li, M., Li, Y., Gaziano, J. M., Wilson, P. W. F., Tsao, P. S., O’Donnell, C. J., Kovesdy, C. P., Pattaro, C., Kottegen, A., Susztak, K., Edwards, T. L., & Hung, A. M. (2019). Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program. Nature Communications, 10(1), 3842. https://doi.org/10.1038/s41467-019-11704-w
Herndon, K., Guidry, T. J., Wassell, K., & Elliott, W. (2020). Characterizing the safety profile of apixaban versus warfarin in moderate to severe chronic kidney disease at a Veterans Affairs hospital. Annals of Pharmacotherapy, 54(6), 554–560. https://doi.org/10.1177/1060028019897053
Kim, Y. A., Lee, Y., & Seo, J. H. (2020). Renal complication and glycemic control in Korean veterans with type 2 diabetes: A 10-year retrospective cohort study. Journal of Diabetes Research, 2020, e9806790. https://doi.org/10.1155/2020/9806790
Kovesdy, C. P., Gosmanova, E. O., Woods, S. D., Fogli, J. J., Rowan, C. G., Hansen, J. L., & Sauer, B. C. (2020). Real-world management of hyperkalemia with patiromer among United States veterans. Postgraduate Medicine, 132(2), 176–183. https://doi.org/10.1080/00325481.2019.1706920
Leef, G. C., Perino, A. C., Askari, M., Fan, J., Ho, P. M., Olivier, C. B., Longo, L., Mahaffey, K. W., & Turakhia, M. P. (2020). Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation: Insights from the Veterans Health Administration. Journal of Pharmacy Practice, 33(5), 647–653. https://doi.org/10.1177/0897190019828270